New Alzheimer's Prevention Strategy Could Stop Cognitive Decline Before It Starts
Antibody therapies show promise for preventing Alzheimer's in cognitively healthy people with disease biomarkers.
246 articles in this topic
Antibody therapies show promise for preventing Alzheimer's in cognitively healthy people with disease biomarkers.
Recent breakthrough drugs targeting amyloid plaques slow cognitive decline, but combination therapies may unlock better outcomes.
New research reveals that inconsistent sleep timing and quality drive faster accumulation of toxic brain proteins linked to Alzheimer's disease.
Researchers modified astrocytes with chimeric antigen receptors to target amyloid plaques, showing promise for Alzheimer's treatment.
Higher cognitive reserve helps maintain mental sharpness despite age-related brain lesions that disrupt neural connections.
Large study finds genetic background doesn't explain mitochondrial damage in neurodegenerative disease, pointing to complex causes.
New research reveals a critical flaw in brain tumor diagnosis that could affect treatment decisions for aggressive cancers.
Editorial raises concerns about influential 2009 study on Cerebrolysin's effects on brain degeneration in Alzheimer's models.
New research reveals how TDP-43 protein causes energy failure in motor neurons, pointing to potential metabolic therapies for ALS.
New research identifies distinct toxic tau protein clusters that drive aggressive Alzheimer's progression, opening doors for personalized treatments.
New research reveals when harmful tau proteins begin accumulating in Down syndrome brains, offering insights into Alzheimer's prevention.
Researchers discover abnormal protein aggregates in skeletal muscle of ALS patients, potentially revealing new disease pathways.